If you missed Thermo Fisher Scientific's webinar on LabRoots that focused on Visikol and Visikol's 3D cell culture assays you [...]
(PRWEB) AUGUST 01, 2018 Visikol CEO Dr. Michael Johnson has announced that through the rapid adoption of its 3Screen™ drug [...]
On October 25th at 12:00 PM EST Dr. Michael Johnson from Visikol will be presenting a webinar sponsored by Science [...]
On October 10th, Visikol will be presenting at TechFest in Boston at the Venture Cafe on 1 Broadway, Cambridge, MA. [...]
A common question for pharmaceutical companies developing therapeutics for neuroscience applications is the passage of small and large molecules across [...]
In the last decade there has been significant research interest in developing improved in vitro models that reduce the need [...]
Application of 3D Cell Culture Models to Evaluating Cancer Drug Efficacy for Precision Medicine The Society of Biomolecular Imaging and [...]